The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
These accolades highlight our unwavering commitment to maintaining the highest safety standards
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The survey inspected ambulances operating throughout the city
Subscribe To Our Newsletter & Stay Updated
